 NEWTON, Mass., June 9, 2021 PRNewswire -- Karyopharm Therapeutics Inc. Nasdaq: KPTI, a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that nine abstracts have been selected for virtual presentation, including one oral presentation, at the upcoming European Hematology Association EHA 2021 Virtual Congress taking place June 9-17, 2021. 